Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

185 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Haploidentical hematopoietic stem cell transplantation: Guidelines from the Francophone society of marrow transplantation and cellular therapy (SFGM-TC)].
Nguyen S, Chalandon Y, Lemarie C, Simon S, Masson D, Dhedin N, Suarez F, Renaud B, Charbonnier A, Yafour N, François S, Duléry R, Blaise D, Yakoub-Agha I, Rubio MT. Nguyen S, et al. Among authors: lemarie c. Bull Cancer. 2016 Nov;103(11S):S229-S242. doi: 10.1016/j.bulcan.2016.09.007. Epub 2016 Nov 11. Bull Cancer. 2016. PMID: 27842860 Review. French.
Reduced-intensity conditioning with Fludarabin, oral Busulfan, and thymoglobulin allows long-term disease control and low transplant-related mortality in patients with hematological malignancies.
Blaise D, Farnault L, Faucher C, Marchetti N, Fürst S, El Cheikh J, Ladaique P, Vey N, Bouabdallah R, Stoppa AM, Lemarie C, Calmels B, Prebet T, Castagna L, Chabannon C, Mohty M, Esterni B. Blaise D, et al. Among authors: lemarie c. Exp Hematol. 2010 Dec;38(12):1241-50. doi: 10.1016/j.exphem.2010.08.012. Epub 2010 Sep 17. Exp Hematol. 2010. PMID: 20850502
Age at transplantation and outcome after autologous stem cell transplantation in elderly patients with multiple myeloma.
El Cheikh J, Kfoury E, Calmels B, Lemarie C, Stoppa AM, Bouabdallah R, Coso D, Schiano De Collela JM, Ladaique P, Gastaut JA, Mohty M, Chabannon C, Blaise D. El Cheikh J, et al. Among authors: lemarie c. Hematol Oncol Stem Cell Ther. 2011;4(1):30-6. doi: 10.5144/1658-3876.2011.30. Hematol Oncol Stem Cell Ther. 2011. PMID: 21460604 Free article.
Comparable outcomes between unrelated and related donors after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation in patients with high-risk multiple myeloma.
El-Cheikh J, Crocchiolo R, Boher JM, Furst S, Stoppa AM, Ladaique P, Faucher C, Calmels B, Castagna L, Lemarie C, De Colella JM, Coso D, Bouabdallah R, Chabannon C, Blaise D. El-Cheikh J, et al. Among authors: lemarie c. Eur J Haematol. 2012 Jun;88(6):497-503. doi: 10.1111/j.1600-0609.2012.01777.x. Epub 2012 Apr 4. Eur J Haematol. 2012. PMID: 22385049
Lenalidomide plus donor-lymphocytes infusion after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with high-risk multiple myeloma.
El-Cheikh J, Crocchiolo R, Furst S, Ladaique P, Castagna L, Faucher C, Granata A, Oudin C, Lemarie C, Calmels B, Stoppa AM, Schiano De Colella JM, Duran S, Chabannon C, Blaise D. El-Cheikh J, et al. Among authors: lemarie c. Exp Hematol. 2012 Jul;40(7):521-7. doi: 10.1016/j.exphem.2012.02.009. Epub 2012 Mar 23. Exp Hematol. 2012. PMID: 22446605 Free article. Clinical Trial.
Acute GVHD is a strong predictor of full donor CD3+ T cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation.
El-Cheikh J, Vazquez A, Crocchiolo R, Furst S, Calmels B, Castagna L, Lemarie C, Granata A, Ladaique P, Oudin C, Faucher C, Chabannon C, Blaise D. El-Cheikh J, et al. Among authors: lemarie c. Am J Hematol. 2012 Dec;87(12):1074-8. doi: 10.1002/ajh.23319. Epub 2012 Aug 22. Am J Hematol. 2012. PMID: 22911907 Free article.
Donor CD3(+) lymphocyte infusion after reduced intensity conditioning allogeneic stem cell transplantation: single-center experience.
El-Cheikh J, Crocchiolo R, Furst S, Ladaique P, Castagna L, Faucher C, Calmels B, Oudin C, Lemarie C, Granata A, Devillier R, Vey N, Bouabdallah R, Chabannon C, Blaise D. El-Cheikh J, et al. Among authors: lemarie c. Exp Hematol. 2013 Jan;41(1):17-27. doi: 10.1016/j.exphem.2012.09.008. Epub 2012 Sep 25. Exp Hematol. 2013. PMID: 23022128
Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCT.
Castagna L, Boubdallah R, Furst S, Coso D, El Cheikh J, Faucher C, Crocchiolo R, Granata A, Chabannon C, Lemarié C, Calmels B, Boher JM, Mohty M, Blaise D. Castagna L, et al. Among authors: lemarie c. Bone Marrow Transplant. 2013 Jun;48(6):794-8. doi: 10.1038/bmt.2012.225. Epub 2012 Dec 10. Bone Marrow Transplant. 2013. PMID: 23222387
Long-term outcome after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with multiple myeloma.
El-Cheikh J, Crocchiolo R, Furst S, Stoppa AM, Ladaique P, Faucher C, Calmels B, Lemarie C, De Colella JM, Granata A, Coso D, Bouabdallah R, Chabannon C, Blaise D. El-Cheikh J, et al. Among authors: lemarie c. Am J Hematol. 2013 May;88(5):370-4. doi: 10.1002/ajh.23412. Epub 2013 Mar 5. Am J Hematol. 2013. PMID: 23460414 Free article.
185 results